Search

Your search keyword '"D. Laune"' showing total 117 results

Search Constraints

Start Over You searched for: Author "D. Laune" Remove constraint Author: "D. Laune"
117 results on '"D. Laune"'

Search Results

1. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

2. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

3. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

4. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

5. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

6. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

9. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study

10. [Adaptation of the General Data Protection Regulation (GDPR) to a smartphone app for rhinitis and asthma (MASK-air®)]

11. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)

12. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1)

13. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

14. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

15. Treatment of allergic rhinitis using mobile technology with real world data: The MASK observational pilot study

16. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

17. Work productivity in rhinitis using cell phones:The MASK pilot study

18. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

19. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

20. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

21. MOESM1 of Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

22. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation

23. Introduction

24. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

25. alpha2-Macroglobulin, the main serum antiprotease, binds beta2-microglobulin, the light chain of the class I major histocompatibility complex, which is involved in human disease

26. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

27. Improved performances of spot multiple peptide synthesis

28. Response of the freshwater marsh species, Panicum hemitomon Schult., to increased salinity

29. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study.

30. Proof-of-concept study of anti-Fel d 1 IgY antibodies in cat food using the MASK-air ® app.

31. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.

32. Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study.

33. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.

34. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

35. Cutoff Values of MASK-air Patient-Reported Outcome Measures.

36. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study.

37. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study.

38. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air ® approach.

39. Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.

40. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference.

41. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air ® real-world data.

42. Development and validation of combined symptom-medication scores for allergic rhinitis.

43. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model.

44. Implementation of the MASK-Air® App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study.

45. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.

46. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy.

47. Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report.

48. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.

49. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.

50. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Catalog

Books, media, physical & digital resources